Citations for
1BST2
BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection.
Urata S, Kenyon E, Nayak D, Cubitt B, Kurosaki Y, Yasuda J, de la Torre JC, McGavern DB.
PLoS Pathog 14(7):e1007172. doi: 10.1371/journal.ppat.1007172. eCollection 2018 Jul. 2018
2BST2
BST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer.
Liu W, Cao Y, Guan Y, Zheng C.
Biotechnol Lett 40(7):1015-1027. doi: 10.1007/s10529-018-2562-z. Epub 2018 May 17. 2018
3BST2, DHX58, MAVS
Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells.
Jin S, Tian S, Luo M, Xie W, Liu T, Duan T, Wu Y, Cui J.
Mol Cell 68(2):308-322.e4. doi: 10.1016/j.molcel.2017.09.005. Epub 2017 Sep 28. 2017
4BST2
Bending of the BST-2 coiled-coil during viral budding.
Ozcan KA, Berndsen CE.
Proteins 85(11):2081-2087. doi: 10.1002/prot.25362. Epub 2017 Aug 12. 2017
5BST2, MARCHF8, NEDD4
Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2.
Roy N, Pacini G, Berlioz-Torrent C, Janvier K.
J Cell Sci 130(9):1596-1611. doi: 10.1242/jcs.195412. Epub 2017 Mar 20. 2017
6BST2, SGTA
The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species.
Waheed AA, MacDonald S, Khan M, Mounts M, Swiderski M, Xu Y, Ye Y, Freed EO.
Sci Rep 6:24934. doi: 10.1038/srep24934. 2016
7BST2
Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains.
Bego MG, Cong L, Mack K, Kirchhoff F, Cohen ÉA.
J Virol 90(22):10236-10246. Print 2016 Nov 15. 2016
8AIFM1, BST2
CD317 Promotes the survival of cancer cells through apoptosis-inducing factor.
Li X, Zhang G, Chen Q, Lin Y, Li J, Ruan Q, Chen Y, Yu G, Wan X.
J Exp Clin Cancer Res 35(1):117. doi: 10.1186/s13046-016-0391-2. 2016
9BST2, MMP14
MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction.
Fan L, Liu L, Zhu C, Zhu Q, Lu S, Liu P.
Int J Mol Sci 17(6). pii: E818. doi: 10.3390/ijms17060818. 2016
10BST2
Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge.
Holmgren AM, Miller KD, Cavanaugh SE, Rall GF.
J Virol 89(21):11011-8. doi: 10.1128/JVI.01745-15. Epub 2015 Aug 26. 2015
11BST2
CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
Gong S, Osei ES, Kaplan D, Chen YH, Meyerson H.
Int J Clin Exp Pathol 8(2):1613-21. eCollection 2015. 2015
12BST2
Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2.
Welbourn S, Kao S, Du Pont KE, Andrew AJ, Berndsen CE, Strebel K.
J Biol Chem 290(6):3740-51. doi: 10.1074/jbc.M114.617639. Epub 2014 Dec 18. 2015
13BST2
An unconventional BST-2 function: down-regulation of transient protein expression.
Narkpuk J, Wanitchang A, Kramyu J, Frantz PN, Jongkaewwattana A, Teeravechyan S.
Biochem Biophys Res Commun 450(4):1469-74. doi: 10.1016/j.bbrc.2014.07.022. Epub 2014 Jul 11. 2014
14BST2
BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus.
Amet T, Byrd D, Hu N, Sun Q, Li F, Zhao Y, Hu S, Grantham A, Yu Q.
Curr Mol Med 14(3):349-60. 2014
15BST2
Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated BST-2/tetherin regulation.
Jones PH, Okeoma CM.
Cell Signal 25(12):2752-61. doi: 10.1016/j.cellsig.2013.08.042. Epub 2013 Sep 13. 2013
16BST2
Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
Sayeed A, Luciani-Torres G, Meng Z, Bennington JL, Moore DH, Dairkee SH.
PLoS One 8(6):e67191. doi: 10.1371/journal.pone.0067191. Print 2013. 2013
17BST2
Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
Serra-Moreno R, Zimmermann K, Stern LJ, Evans DT.
PLoS Pathog 9(7):e1003487. doi: 10.1371/journal.ppat.1003487. Epub 2013 Jul 11. 2013
18BST2
CD317/tetherin is an organiser of membrane microdomains.
Billcliff PG, Rollason R, Prior I, Owen DM, Gaus K, Banting G.
J Cell Sci 126(Pt 7):1553-64. doi: 10.1242/jcs.112953. Epub 2013 Feb 1. 2013
19BST2, IL27
IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN.
Guzzo C, Jung M, Graveline A, Banfield BW, Gee K.
Sci Rep 2:974. doi: 10.1038/srep00974. Epub 2012 Dec 13. 2012
20BST2
The role of the structural domains of human BST-2 in inhibiting the release of xenotropic murine leukemia virus-related virus.
Hu S, Pang X, Li J, Cen S, Jin Q, Guo F.
Biochem Biophys Res Commun 428(1):17-23. doi: 10.1016/j.bbrc.2012.10.001. Epub 2012 Oct 6. 2012
21BST2
The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.
Janvier K, Pelchen-Matthews A, Renaud JB, Caillet M, Marsh M, Berlioz-Torrent C.
PLoS Pathog 7(2):e1001265. 2011
22BST2
Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release.
Swiecki M, Scheaffer SM, Allaire M, Fremont DH, Colonna M, Brett TJ.
J Biol Chem 286(4):2987-97. Epub 2010 Nov 17. 2011
23BST2
IFN-γ-induced BST2 mediates monocyte adhesion to human endothelial cells.
Yoo H, Park SH, Ye SK, Kim M.
Cell Immunol 267(1):23-9. Epub 2010 Nov 3. 2011
24BST2
Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses.
Sauter D, Vogl M, Kirchhoff F.
Hum Mutat 32(11):1243-5. doi: 10.1002/humu.21571. Epub 2011 Aug 11. 2011
25BST2
BST-2/tetherin: a new component of the innate immune response to enveloped viruses.
Evans DT, Serra-Moreno R, Singh RK, Guatelli JC.
Trends Microbiol 18(9):388-96. Epub 2010 Aug 3. Review. 2010
26BST2
BST-2 diminishes HIV-1 infectivity.
Zhang J, Liang C.
J Virol 84(23):12336-43. Epub 2010 Sep 22. 2010
27BST2
Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations.
Schubert HL, Zhai Q, Sandrin V, Eckert DM, Garcia-Maya M, Saul L, Sundquist WI, Steiner RA, Hill CP.
Proc Natl Acad Sci U S A 107(42):17951-6. Epub 2010 Sep 29. 2010
28BST2
Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
Tokarev A, Skasko M, Fitzpatrick K, Guatelli J.
AIDS Res Hum Retroviruses 25(12):1197-210. Review. 2009
29BST2
Tetherin inhibits HIV-1 release by directly tethering virions to cells.
Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD.
Cell 139(3):499-511. 2009
30BST2
Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.
BMC Cancer 9:102. 2009
31BST2
A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells.
Rollason R, Korolchuk V, Hamilton C, Jepson M, Banting G.
J Cell Biol 184(5):721-36. 2009
32BST2
Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth.
Ishikawa J, et al.
Genomics 26 : 527-534. 1995